Expansion of the midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin

Journal of Clinical Microbiology

Volumn 49, Issue 11, 2011, Pages 3855-3859

  Lovrich, Steven D ^a   Jobe, Dean A ^a   Kowalski, Todd J ^a   Policepatil, Seema M ^a   Callister, Steven M ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ADOLESCENT; ADULT; AGED; ANAPLASMA PHAGOCYTOPHILUM; ARTICLE; BACTERIUM DETECTION; BORRELIA BURGDORFERI; CHILD; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; FEMALE; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; IXODES SCAPULARIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; BLOOD; CHILD; DNA, BACTERIAL; EHRLICHIOSIS; FEMALE; HUMANS; IXODES; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; WISCONSIN; YOUNG ADULT;

ANAPLASMA PHAGOCYTOPHILUM; BORRELIA BURGDORFERI; IXODES SCAPULARIS; IXODIDA;

EID: 80355145107     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05025-11     Document Type: Article

References (30)

1. Aguero-Rosenfeld, M. E. 2002. Diagnosis of human granulocytic ehrlichiosis: state of the art. Vector Borne Zoonotic Dis. 2:233-239.
2. Aguero-Rosenfeld, M. E., et al. 2002. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J. Clin. Microbiol. 40:2612-2615. (Pubitemid 34752170)
3. Bakken, J. S., and J. S. Dumler. 2000. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 31:544-560.
4. Bakken, J. S., et al. 1994. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA 272:212-218. (Pubitemid 24209083)
5. Bakken, J. S., I. Haller, D. Riddell, J. J. Walls, and J. S. Dumler. 2002. The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin. Infect. Dis. 34:22-27. (Pubitemid 33152661)
6. Bakken, J. S., et al. 1998. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin. Infect. Dis. 27:1491-1496. (Pubitemid 29242427)
7. Bakken, J. S., et al. 1996. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275:199-205. (Pubitemid 26028560)
8. Beall, M. J., et al. 2008. Serological and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia species in dogs from Minnesota. Vector Borne Zoonotic Dis. 8:455-464.
9. Bruckbauer, H. R., V. Preac-Mursic, R. Fuchs, and B. Wilske. 1992. Cross-reactive proteins of Borrelia burgdorferi. Eur. J. Clin. Microbiol. Infect. Dis. 11:224-232.
10. Callister, S. M., W. A. Agger, R. F. Schell, and J. L. E. Ellingson. 1988. Borrelia burgdorferi infection surrounding La Crosse, Wisconsin. J. Clin. Microbiol. 26:2632-2636. (Pubitemid 19001585)
11. Chen, S. M., J. S. Dumler, J. S. Bakken, and D. H. Walker. 1994. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32:589-595.
12. College of American Pathologists, Commission on Laboratory Accreditation. 2009. Molecular pathology checklist. College of American Pathologists, Northfield, IL.
13. Courtney, J. W., L. M. Kostelnik, N. S. Zeidner, and R. F. Massung. 2004. Multiplex real-time PCR for detection of Anaplasma phagocytophilum and Borrelia burgdorferi. J. Clin. Microbiol. 42:3164-3168. (Pubitemid 38938075)
14. Dawson, J. E., D. B. Fishbein, T. R. Eng, M. A. Redus, and N. R. Green. 1990. Diagnosis of human ehrlichiosis with the indirect fluorescent antibody test: kinetics and specificity. J. Infect. Dis. 162:91-95. (Pubitemid 20223954)
15. Demma, L. C., R. C. Holman, J. H. McQuiston, J. W. Krebs, and D. L. Swerdlow. 2006. Human monocytic ehrlichiosis and human granulocytic ehrlichiosis in the United States, 2001-2002. Ann. N. Y. Acad. Sci. 1078:118-119.
16. Dumler, J. S., et al. 2005. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg. Infect. Dis. 11:1828-1834. (Pubitemid 43361465)
17. Dumler, J. S., J. E. Madigan, N. Pusterla, and J. S. Bakken. 2007. Ehrlichiosis in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin. Infect. Dis. 45:S45-S51.
18. Grab, D. J., E. Nyarko, N. C. Barat, O. V. Nikolskaia, and J. S. Dumler. 2007. Anaplasma phagocytophilum-Borrelia burgdorferi coinfection enhances chemokine, cytokine, and matrix metalloprotease expression by human brain microvascular endothelial cells. Clin. Vaccine Immunol. 14:1420-1424. (Pubitemid 350304034)
19. Hardalo, C., V. Quagliarello, and J. S. Dumler. 1995. Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin. Infect. Dis. 21:910-914.
20. Horowitz, H. W., et al. 1998. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin. Infect. Dis. 27:1314-1317. (Pubitemid 29242490)
21. Jackson, C. A., S. D. Lovrich, W. A. Agger, and S. M. Callister. 2002. Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent. J. Clin. Microbiol. 40:2070-2073. (Pubitemid 34596386)
22. Kolbert, C. 1996. Detection of the agent of human granulocytic ehrlichiosis by PCR, p. 106-111. In D. Persing (ed.), PCR protocols for emerging infectious diseases. ASM Press, Washington, DC.
23. Massung, R. F., and K. G. Slater. 2003. Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. J. Clin. Microbiol. 41:717-722. (Pubitemid 36187435)
24. Morissette E., et al. 2009. Diversity of Anaplasma phagocytophilum strains, U. S. A. Emerg. Infect. Dis. 15:928-931.
25. Murphy, C. I., et al. 1998. Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family. Infect. Immun. 66:3711-3718. (Pubitemid 28347828)
26. Ramsey, A. H., E. A. Belongia, C. M. Gale, and J. P. Davis. 2002. Outcomes of treated human granulocytic ehrlichiosis cases. Emerg. Infect. Dis. 8:398-401. (Pubitemid 34415202)
27. Telford, S. R., et al. 1996. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc. Natl. Acad. Sci. U. S. A. 93:6209-6214.
28. Wong, S. J., G. S. Brady, and J. S. Dumler. 1997. Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State. J. Clin. Microbiol. 35:2198-2205. (Pubitemid 27349781)
29. Wormser, G. P., et al. 2006. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43:1089-1134. (Pubitemid 44637131)
30. Zhi, N., et al. 1998. Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to diagnosis. J. Clin. Microbiol. 36:1666-1673. (Pubitemid 28226050)